Dexcom Inc (DXCM) Common Stock USD0.001

Sell:$60.30Buy:$60.47$0.58 (0.97%)

NASDAQ:1.44%
Prices delayed by at least 15 minutes
Sell:$60.30
Buy:$60.47
Change:$0.58 (0.97%)
Deal now
Prices delayed by at least 15 minutes
Sell:$60.30
Buy:$60.47
Change:$0.58 (0.97%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The Company enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.

Key people

Kevin R. Sayer
Chairperson of the Board, President, Chief Executive Officer
Jereme M. Sylvain
Chief Financial Officer, Executive Vice President
Jacob Steven Leach
Executive Vice President, Chief Operating Officer
Sadie M. Stern
Chief Human Resources Officer, Executive Vice President
Michael J. Brown
Executive Vice President, Chief Legal Officer
Mark G. Foletta
Lead Independent Director
Steven R. Altman
Independent Director
Nicholas Augustinos
Independent Director
Richard Alexander Collins
Independent Director
Karen M. Dahut
Independent Director

Key facts

  • EPIC
    DXCM
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US2521311074
  • Market cap
    $23.46bn
  • Employees
    10,300
  • Shares in issue
    410.31m
  • Exchange
    NASDAQ
  • Index
    S&P 500, NASDAQ 100 Index, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.